» Articles » PMID: 37787527

Supplementation Improves Glucose Tolerance in Intestinal Knockout Mice During the Daily Light to Dark Transition

Overview
Journal mSystems
Specialty Microbiology
Date 2023 Oct 3
PMID 37787527
Authors
Affiliations
Soon will be listed here.
Abstract

Alterations in the intestinal environment are associated with various diseases, and FFAR4 is abundantly enriched in the intestine, where it has been shown to have the ability to regulate intestinal hormone secretion and intestinal microbiota; here, we confirmed previous reports. Meanwhile, we found that intestinal FFAR4 regulates glucagon-like peptide 1 secretion by decreasing abundance and show that such change is associated with the level of glucose utilization at ZT12 in mice. Intestinal FFAR4 deficiency leads to severely impaired glucose tolerance at the ZT12 moment in mice, and supplementation ameliorates the abnormal glucose utilization at the ZT12 moment caused by FFAR4 deficiency, which is very similar to the dawn phenomenon in diabetic patients. Collectively, our data suggest that intestinal deteriorates glucose tolerance at the daily light to dark transition by affecting .

Citing Articles

for the Prevention of Type 2 Diabetes and Obesity: A Meta-Analysis of Animal Studies.

Liu E, Ji X, Zhou K Nutrients. 2024; 16(20).

PMID: 39458436 PMC: 11510203. DOI: 10.3390/nu16203440.


: A promising probiotic against inflammation and metabolic disorders.

Zhao Y, Yang H, Wu P, Yang S, Xue W, Xu B Virulence. 2024; 15(1):2375555.

PMID: 39192579 PMC: 11364076. DOI: 10.1080/21505594.2024.2375555.


Dietary Polyphenols Support Growth via Mediation of the Gastrointestinal Redox Environment.

Van Buiten C, Seitz V, Metcalf J, Raskin I Antioxidants (Basel). 2024; 13(3).

PMID: 38539838 PMC: 10967430. DOI: 10.3390/antiox13030304.

References
1.
Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L . A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2016; 23(1):107-113. DOI: 10.1038/nm.4236. View

2.
Oliveira de Souza C, Sun X, Oh D . Metabolic Functions of G Protein-Coupled Receptors and β-Arrestin-Mediated Signaling Pathways in the Pathophysiology of Type 2 Diabetes and Obesity. Front Endocrinol (Lausanne). 2021; 12:715877. PMC: 8419444. DOI: 10.3389/fendo.2021.715877. View

3.
Cheng J, Yang Z, Ge X, Gao M, Meng R, Xu X . Autonomous sensing of the insulin peptide by an olfactory G protein-coupled receptor modulates glucose metabolism. Cell Metab. 2022; 34(2):240-255.e10. DOI: 10.1016/j.cmet.2021.12.022. View

4.
Alvarado M, Kum H, Gonzalez Coronado K, Foster M, Ortega P, Lawley M . Barriers to Remote Health Interventions for Type 2 Diabetes: A Systematic Review and Proposed Classification Scheme. J Med Internet Res. 2017; 19(2):e28. PMC: 5329647. DOI: 10.2196/jmir.6382. View

5.
Shin N, Lee J, Lee H, Kim M, Whon T, Lee M . An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2013; 63(5):727-35. DOI: 10.1136/gutjnl-2012-303839. View